Recce Pharmaceuticals Ltd (ASX:RCE) Share Price and News - StockTrack

Market Cap (4-Jul) $86,511,600 (718th)	Close (30-Jun) $0.63 0 (0%)	Volume (30-Jun) 55,179	Shortsold (19-Jun) 190,561 (0.07%) (455th)
52w High $0.57	52w Low $0.275	P/E -	EPS -0.09

	Subject
	RCE RCE Ann: Pause in Trading
	1 (current) 2 3
	RCE RCE Ann: R327 Phase I Clinical Trial Registered on ANZCTR
	RCE RCE Ann: Appendix 4G
	RCE RCE Ann: Annual Report to shareholders
	RCE RCE Ann: Appendix 4E
	RCE RCE Ann: Change in substantial holding
	RCE RCE Ann: Recce Receives Further Innovation Connections Grant
	RCE RCE Ann: Appendix 4C and Activity Report
	RCE RCE Ann: Corporate Presentation
	RCE RCE Ann: Anti-Viral Patent Granted in USA for RECCE Anti-Infectives
	RCE RCE Ann: Anti-Viral Patent Granted in China
	RCE RCE Ann: Outstanding Efficacy Against Flesh-Eating Bacteria
	RCE RCE Ann: Multiple Patients Dosed in Topical Phase I/II Clinical Trial
	RCE RCE Ann: Bonus Canadian R&D Rebate Received
	RCE RCE Ann: Change of Director's Interest Notices - J Graham & M Dilizia
	RCE RCE Ann: Recce Pharmaceuticals to Present at World Microbe Forum
	RCE RCE Ann: Recce to Present at MST Access Investor Conference
	RCE RCE Ann: Corporate Presentation - EU Non-Deal Roadshow
	RCE RCE Ann: Recce Clinical Pipeline Update
	RCE RCE Ann: R327 Demonstrates World First Multiple Mechanisms of Action
	RCE RCE Ann: R327 to Stage 2 of SARS-CoV-2 Antiviral Screening at CSIRO
	RCE RCE Ann: Positive Data on RECCE 327 Against All Six ESKAPE Pathogens
	RCE RCE Ann: Appendix 4C and Activity Report
	RCE RCE Ann: RECCE 327 Registered for Topical Burns Study in Humans
	RCE RCE Ann: Positive Sinusitis Patient Update - Special Access Scheme
	RCE RCE Ann: Positive Sinusitis Data Against Infection
	RCE RCE Ann: Anti-Viral Patent Granted in EU for RECCE Anti-Infectives
	RCE RCE Ann: Pew Charitable Trusts adds R327 to Antibiotic Treatment List
	RCE RCE Ann: S&P DJI Announces March 2021 Quarterly Rebalance
	RCE RCE Ann: Recce Presenting at H.C. Wainwright Life Sciences Conference
	RCE RCE Ann: Recce Pharmaceuticals Dual Lists on Frankfurt Stock Exchange
	RCE RCE Ann: Change of Director's Interest Notice
	RCE RCE Ann: Change of Director's Interest Notice
	RCE RCE Ann: Change of Director's Interest Notice
	RCE RCE Ann: Change of Director's Interest Notice
	RCE RCE Ann: Change of Director's Interest Notice
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Appendix 2A
	RCE RCE Ann: Appendix 4D and Half Yearly Report
	RCE RCE Ann: Recce Applies for Dual Listing on Frankfurt Stock Exchange
	RCE RCE Ann: Appendix 3G
	RCE RCE Ann: Fiona Stanley Hospital Phase I/II Clinical Trial Agreement
	RCE RCE Ann: Further Encouraging COVID Results at Doherty
	RCE RCE Ann: R&D Incentive Rebate Received
	RCE RCE Ann: Appendix 4C and Activity Report
	RCE RCE Ann: Cleansing Statement
	RCE RCE Ann: Appendix 2A
	RCE RCE Ann: Corporate Presentation
	RCE RCE Ann: Positive Intranasal Animal Data against SARS-CoV-2 in Study
	RCE RCE Ann: Business Update

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
03-Jul	$0.30	21,000	0.00 (0.00%)
02-Jul	$0.30	96,614	+0.01 (3.45%)
30-Jun	$0.29	556,441	-0.02 (6.45%)
27-Jun	$0.31	82,292	+0.01 (3.33%)
26-Jun	$0.30	101,281	+0.01 (3.45%)
24-Jun	$0.29	127,792	-0.01 (1.69%)
23-Jun	$0.30	133,150	-0.01 (1.67%)
20-Jun	$0.30	127,651	+0.01 (1.69%)
19-Jun	$0.30	172,965	-0.01 (3.28%)
18-Jun	$0.31	174,328	0.00 (0.00%)
16-Jun	$0.31	82,188	-0.01 (3.17%)
13-Jun	$0.32	164,503	-0.02 (5.97%)
12-Jun	$0.34	114,757	+0.03 (9.84%)
06-Jun	$0.31	532,258	-0.02 (4.69%)
05-Jun	$0.32	161,800	0.00 (0.00%)
5 up, 7 down, and 3 flat days

High $0.63	Low $0.59	Trades 32	Turnover $33,720	Volume 55,179
30 June 2023 at 4:10pm

High $0.63	Low $0.59	Trades 32	Turnover $33,720	Volume 55,179
30 June 2023 at 4:10pm

Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals

$0.625 0.005 (0.81%)

$0.625 0.005 (0.81%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Recce Pharmaceuticals Ltd Health Care Blood Pharmaceuticals

$0.625 0.005 (0.81%)

$0.625 0.005 (0.81%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Recce Pharmaceuticals Ltd Health Care
Blood Pharmaceuticals